[Skip to content]

Cancer Advice - from leading UK Cancer Specialists
Find information
In this section...
On this site...

Gardasil Hpv (human Papilloma Virus) vaccine prevents high grade Cin

Advances in Gynaecological cancer are very welcome and a very interesting study FUTURE II trial is coming to its end and early reports are out. This was a prospective randomised trial evaluating the incidence of HPV (16,18) related cervical intraepithelial neoplasia (CIN - the pre-cancerous condition which later leads onto cervical cancer itself)or cervical adenocarcinoma in situ (AIS) in more than 12,000 women aged between 16 and 23 randomised to receive a HPV recombinant vaccine or a placebo. Women were recruited from 90 centres in 12 countries. There are early data demonstrating a huge decrease in the incidence of the disease in the vaccinated group.